Bristows LLP

Bristows' Podcast

Business EN ↓ 97 episodes

Never content to do the bare minimum, we've always been at the forefront of change. You could say we are and always have been a bit different from other law firms. Our legal expertise joined up with our science and technology backgrounds means we understand your business and can talk the same language. And that's essentially what we cover in this podcast. A truly independent approach to litigation, transactions and advice throughout the world.

Be sure to visit the podcast's website and support the creator: www.bristows.com

Author

Bristows LLP

Category

Business

Podcast website

www.bristows.com

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Spotlight on... Women's health and innovation: Navigating Femtech regulatory compliance in the EU – A legal conversation 22.12.2025

Those working in the Femtech space have a difficult regulatory framework to navigate in the EU. For products that qualify as a medical device, the EU Medical Device Regulation imposes onerous obligations. In addition, the AI Act, as it stands, add additional regulatory requirements for devices including AI.  In this podcast Xisca Borrás and Ellie Handy discuss when software will qualify as a medic...

Spotlight on... Women's health and innovation: Early-stage funding for FemTech companies in the UK 10.12.2025

The FemTech sector, which focuses on technology for women’s health and wellness, is experiencing rapid growth in the UK. Out of the 540 active FemTech start-ups in Europe in 2023, 31.8% were based in the UK, and the UK is ranked second globally (behind the US) in terms of investment in the FemTech sector. In this podcast, Sophie Rees , Anna Honey and Gabriela Necula outline the main early-stage fu...

Autumn Budget 2025: key business tax announcements 27.11.2025

Finding reasons to be cheerful…hear our tax team’s key takeaways from the Budget 2025 which was announced on Wednesday, 26 November 2025. After much speculation and the odd leak, we unpick the negative predictions that did not come to pass and share our top three tax ‘good news’ stories. All information was correct at the time of recording.

Spotlight on... Women's health and innovation: University spin-outs in women’s health innovation’ 20.11.2025

In this episode of our Spotlight on Women's Health and Innovation podcast, Laura Harwood and Melissa Dix explore how university spin-outs can offer an effective mechanism for commercialising research, particularly in the women’s health space. They discuss the way in which university spin-outs are bringing research-driven solutions to market, and examine the key contractual considerations rega...

Spotlight on... Women's health and innovation: Navigating key GDPR challenges 18.09.2025

In the very first episode of our Spotlight on Women's Health and Innovation podcast, data protection associates Kiran Sidhu and Subha Kumar discuss how to navigate key GDPR challenges in the women’s health space. They offer practical advice when launching a new product or service in this sector and give top-tips on how to stay compliant and avoid regulatory traps. 

Navigating the Future - Corporate Law and AI - Investing in UK companies 19.06.2025

In the third and final episode of our series exploring Corporate Law and AI, our experts, Partner Nick Cross and Associate Oliver Alsop , delve into a crucial piece of legislation for anyone considering investing in UK companies in the AI sector: the National Security Investment Act 2021 (NSIA).

Medical device software market on the brink? The AI Act alarm bells are ringing - Part 3 04.06.2025

In this final episode of our three-part mini series on the EU AI Act and its implications for manufacturers of medical devices, Marc Dautlich and Alex Denoon look in detail at Annex V of the Act.  Annex V of the EU AI Act requires, amongst other things, that a manufacturer provide the Notified Body making a conformity assessment with a statement that the high risk AI system that is being assessed...

Medical device software market on the brink? The AI Act alarm bells are ringing - Part 2 28.05.2025

As rumours swirl of a delay to the date of application of the AI Act, here is part 2 of specialists Marc Dautlich and Alex Denoon's podcast. In this episode, they delve further into Marc’s territory – the principles based GDPR - and note an uncomfortable practical constraint hidden away in Annex V of the EU AI Act. This issue wasn’t addressed in Team-NB’s Position Paper, but is likely to be a...

Medical device software market on the brink? The AI Act alarm bells are ringing - Part 1 19.05.2025

Team-NB, representing the majority of Notified Bodies for EU MDR and IVDR medical devices, has issued a stark warning: the implementation of the EU AI Act carries a significant risk of major disruption to the medical device software sector. Their recently published Position Paper doesn't hold back, highlighting critical shortcomings in the implementation framework and emphasising the dwindlin...

Navigating the challenges of investing in or acquiring companies utilising Agentic AI 23.04.2025

In the second episode of our series exploring Corporate Law and AI, our experts, Partner Iain Redford (Corporate & Tax) and Partner Vik Khurana (Commercial Technology), highlight some of the key risks which are likely to arise in doing deals with the next generation of AI companies with suggestions about ways to mitigate those risks. Find all the episodes as we release them here , and don’t fo...

Navigating the Future - Corporate Law and AI - Recognising value in AI transactions 27.03.2025

In the first episode of our series exploring Corporate Law and AI, our experts, Partner Vik Khurana (Commercial Technology) and Of Counsel Richard Swaine (Corporate & Tax), focused on the current state of AI transactional work and recognising and protecting value. Find all the episodes as we release them here , and don’t forget to subscribe! Note: All information was correct at the time of rec...

Rapid reaction: CJEU clarifies jurisdictional issues in cross-border patent disputes 25.02.2025

Following the CJEU’s landmark decision in the BSH v Electrolux case (C-339/22), patent litigators Andrew Bowler and Gregory Bacon discuss the three questions referred by the Swedish Court of Appeal to the European court. Explore our more detailed analysis here Note : All information was correct at the time of recording.

Biotech Review of the Year: Six months on 25.06.2024

It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our editors, Greg Bacon , Xisca Borrás , and Will Hewitt , thought now would be a great time to catch up and discuss any developments since the launch. You can also find written updates on the following articles here : Integrating generative AI into the life scien...

Tech M&A series - Acquihire deals - key considerations and potential pitfalls 29.05.2024

In this episode our experts Iain Redford (corporate), Miranda Cass (tax) and Gareth Wadley (employment and global mobility) set out the key considerations and potential pitfalls involved in Acquihire deals - an increasing trend we see from across the Atlantic as strategic buyers and institutions look to acquire the best talent and technology to drive innovation. Find all the episodes as we release...

Tech M&A series - Adtech M&A 21.02.2024

In this episode of Tech M&A, our experts, Jamie Drucker and Richard Swaine look at the regulatory challenges facing Adtech companies and consider how commercial and legal diligence - and approach to transaction risk - in Adtech M&A may have to refocus in the light of those challenges.  Find all the episodes as we release them here , and don’t forget to subscribe! Note: All information was...

Tech M&A series - Trends in Medtech M&A 23.10.2023

In this episode of Tech M&A, our experts, Sophie Rees and Jamie Hatzel discuss some of the recent trends affecting medtech M&A, in particular recent regulatory changes which are affecting the evolution of the sector. They also discuss some of the M&A pitfalls which have arisen out of those trends – and how focussed due diligence can help investors avoid them. Find all the episodes as w...

Ep 1: Full Disclosure - Introducing the Statutory Disclosure Regime consultation 10.10.2023

Chris Bates and Vivien Zhu introduce the UK government’s consultation on a statutory regime for disclosure of transfers of value to the healthcare sector by the life sciences industry. Chris talks about the historical context of voluntary schemes for disclosures of transfers of value, while Vivien introduces the data protection implications of such disclosures. The Statutory Disclosure Regime cons...

Ep 2: Full Disclosure - the Statutory Disclosure Regime proposals in detail 10.10.2023

Jamie Hatzel and Vivien Zhu delve into some of the finer details of the Statutory Disclosure Regime proposals, including the scope of the proposed regime and the role that voluntary disclosure schemes could continue to play once the regime comes into force. Vivien also talks through how the Statutory Disclosure Regime should prompt some companies to consider whether their data protection arrangeme...

Ep 3: Full Disclosure - the Statutory Disclosure Regime and the medtech sector 10.10.2023

Chris Bates and Jamie Hatzel round out this three-part series with a discussion of the likely impact of the Statutory Disclosure Regime proposals on the medtech sector, and how medtech will have to play catch-up to remain compliant once the Statutory Disclosure Regime comes into force.  The Statutory Disclosure Regime consultation closes on 16 October 2023. To learn more and submit a response, see...

Tech M&A series - Generative AI 03.10.2023

In this episode, experts Chris Devlin and Julia Cockroft explore the impact the National Security and Investment Act 2021 has had on transactions involving companies active in AI. The conversation then moves onto the valuable R&D tax reliefs that might be available to businesses harnessing the power of AI and how those reliefs should be taken into account as part of deal negotiations. Find all...

InterDigital v Lenovo - Initial impressions 03.04.2023

In this episode, Luke Maunder discusses the long-awaited FRAND judgment of Mr Justice Mellor with special guest star Dr Myles Jelf. Luke and Myles delve into the decision and set out the key information you need to know. 

Free-standing FRAND actions green lit 20.12.2022

In this quick update, senior associates and IP specialists Luke Maunder and Naomi Hazenberg  discuss the recent decision in Kigen v Thales, which considers the jurisdiction of the court for a claim that included FRAND declarations that were free-standing and/or tied to declarations of invalidity and non-essentiality.

FRAND injunctions and undertakings 06.12.2022

Senior associates and IP specialists Luke Maunder and Naomi Hazenberg discuss the development of the English FRAND injunction and the timing of when an undertaking to enter a FRAND licence is required. 

FRAND methodologies before the British Courts 28.11.2022

Senior associates and IP specialists Luke Maunder and Naomi Hazenberg go back to the future to look at FRAND methodologies before the British Courts. They begin by looking at what was done in the seminal Unwired Planet case, before moving on to the detail of the unresolved issues including those that are up for consideration in the cases of InterDigital v Lenovo and Optis v Apple . For the true ec...

How have British Courts treated patent pools? 14.11.2022

Senior associates and IP specialists, Luke Maunder and Naomi Hazenberg ,  look at how the British Courts have treated patent pools, before delving into some of the issues they present in litigation. They also cover suggestions that the principle of pool licensing could apply on the other side of the fence, looking at licensing negotiation groups and approaches that seek to achieve a similar object...

Listen to the Bristows' Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.